XML 73 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
Goodwill And Other Intangibles (Narrative) (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2016
Mar. 31, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Goodwill [Line Items]              
Amortization of intangible assets $ 191,000,000   $ 212,800,000   $ 454,077,000 $ 424,500,000  
Impairment of intangible assets         586,232,000    
Asset impairment charges 725,044,000   39,951,000   929,006,000 169,576,000  
Goodwill impairment charges         288,744,000    
Goodwill 4,447,314,000       4,447,314,000   $ 4,729,395,000
Somar | Disposal Group, Held-for-sale, Not Discontinued Operations              
Goodwill [Line Items]              
Impairment of intangible assets 89,500,000            
Asset impairment charges         9,900,000    
Goodwill impairment charges 25,700,000            
2016 US Generic Pharmaceuticals Restructuring | Asset Impairment Charges              
Goodwill [Line Items]              
Impairment of intangible assets           $ 100,300,000  
U.S. Generic Pharmaceuticals              
Goodwill [Line Items]              
Impairment of intangible assets 268,200,000 $ 72,700,000          
Asset impairment charges     $ 40,000,000 $ 29,300,000      
Goodwill impairment charges $ 0       0    
Discount rate applied to estimated cash flows 9.00%            
Goodwill $ 3,531,301,000       3,531,301,000   3,531,301,000
U.S. Generic Pharmaceuticals | 2017 US Generic Pharmaceuticals Restructuring              
Goodwill [Line Items]              
Asset impairment charges 57,500,000            
U.S. Generic Pharmaceuticals | 2016 US Generic Pharmaceuticals Restructuring | Asset Impairment Charges              
Goodwill [Line Items]              
Asset impairment charges       $ 100,300,000      
U.S. Branded Pharmaceuticals              
Goodwill [Line Items]              
Asset impairment charges $ 20,600,000            
Goodwill impairment charges         180,430,000    
Discount rate applied to estimated cash flows 9.50%            
Goodwill $ 828,818,000       828,818,000   1,009,248,000
U.S. Branded Pharmaceuticals | Accounting Standards Update, 2017-04              
Goodwill [Line Items]              
Asset impairment charges 180,400,000            
U.S. Branded Pharmaceuticals | Opana              
Goodwill [Line Items]              
Asset impairment charges 31,500,000            
International Pharmaceuticals              
Goodwill [Line Items]              
Asset impairment charges   82,600,000          
Goodwill impairment charges         108,314,000    
Goodwill 87,195,000       $ 87,195,000   $ 188,846,000
International Pharmaceuticals | Serelaxin In-Process Research and Development Intangible Assets              
Goodwill [Line Items]              
Asset impairment charges   $ 45,500,000          
Paladin Labs Inc.              
Goodwill [Line Items]              
Discount rate applied to estimated cash flows         10.00%    
Goodwill $ 87,000,000       $ 87,000,000